.webp?sfvrsn=bbef8c36_1)
Gleneagles HealthCity Chennai recently celebrated a significant milestone in clinical excellence, completing over 100 robotic-assisted cancer surgeries within a year.
At a media event in July, the hospital showcased its advanced da Vinci Xi System, which is transforming cancer treatment. A standout moment was India’s first robotic cytoreductive surgery with heated intraperitoneal chemotherapy, performed on an 82-year-old woman with stage 3 ovarian cancer.
“The da Vinci Xi System has allowed us to perform over 100 complex robotic cancer surgeries with unmatched precision, enhancing patient outcomes,” said Prof Dr S Rajasundaram, Director of Gleneagles Cancer Institute. "This minimally invasive approach, with 3D vision and magnification, accelerates recovery, reduces blood loss, and mininises complication risks.”
Anurag Yadav, CEO of Gleneagles Healthcare India, emphasised, “This milestone shows our commitment to advancing medical technology and delivering superior clinical care.”
Looking ahead, Dr Nageswar Rao, CEO of Gleneagles HealthCity Chennai highlighted the future of robotic-assisted surgeries: “As more robotic programs are implemented, costs will decrease, making these surgeries more accessible. With 5G and AI advancements, surgeons will soon be able to operate remotely across vast distances.”
Related Stories
Gleneagles Hospital Johor Becomes First in Malaysia to Achieve ERAS® Qualification in Knee Arthroplasty
Recovery from surgery often begins long before a patient enters the operating theatre. At IHH’s Gleneagles Hospital Johor, a multidisciplinary team has been reshaping that recovery journey through a more coordinated and patient-centred approach to knee replacement care.
IHH Healthcare Advocates Long-term Sustainability Thinking at Future Economy Conference
At the recent Future Economy Conference 2026, IHH's Group Chief Sustainability Officer Yasemin Tecmen Stubbe shared why sustainability remains critical to business resilience and long-term value creation, particularly amid growing geopolitical uncertainty, climate risks and supply chain disruptions.
IHH Healthcare Aligns Teams in Malaysia and Singapore on Future-ready Healthcare Priorities
IHH Healthcare recently brought together employees across Malaysia’s Southern Region and Singapore for its Country Town Halls, reinforcing the Group’s focus on strengthening current healthcare capabilities while preparing for the evolving needs of the future.
Gleneagles Hong Kong and HKTDC Co-organised a Thematic Session at The Asia Summit on Global Health 2026
Titled “Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution”, the thematic panel session co-organised by Gleneagles Hong Kong and Hong Kong Trade Development Council (HKTDC) was moderated by Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia.
Acibadem Performed Türkiye's First Experimental 5G‑Supported Remote Robotic Surgical Simulation
The simulation was conducted between Acibadem Maslak Hospital and Acibadem University CASE (Advanced Medical Simulation and Training Center).
Gleneagles JPMC performs first VARIPULSE procedure in Borneo
Cardiovascular Laboratory at Gleneagles JPMC continues to evolve, marked by new milestones in advanced heart rhythm procedures.
